pharma · Chemotherapy Induced Neuropathic Pain · DWTX
Dogwood Therapeutics
Dogwood Therapeutics is a pharma organization headquartered in Alpharetta, USA. It trades on NYSE under ticker DWTX. Primary therapeutic focus areas include Chemotherapy Induced Neuropathic Pain. NovaPharmaNews links 1 c
Alpharetta, USA HQ
2020 Founded
9 Employees
Public company Type
DWTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Alpharetta, USA
- Founded
- 2020
- Employees
- 9
- Programs
- 1
- Drugs
- 2
- Patents
- 7
Halneuron
Phase 2 · small molecule · Chemotherapy Induced Neuropathic Pain
Halneuron for Chemotherapy Induced Neuropathic Pain is a Phase 2 program (small_molecule) at Dogwood Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code HAL-CINP-203
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Dogwood Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Chemotherapy Induced Neuropathic Pain
- Status
- active
- Trials
- 1